Bank of New York Mellon Corp - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$17,000
-56.4%
85,830
-0.3%
0.00%
Q3 2018$39,000
-9.3%
86,130
+0.3%
0.00%
Q2 2018$43,000
-97.2%
85,830
-87.0%
0.00%
Q1 2018$1,539,000
-21.5%
660,261
-4.4%
0.00%
-100.0%
Q4 2017$1,961,000
+10.2%
690,631
+11.0%
0.00%
Q3 2017$1,780,000
+19.9%
622,430
+3.6%
0.00%
Q2 2017$1,484,000
-23.6%
600,525
+11.6%
0.00%
-100.0%
Q1 2017$1,943,000
+3.0%
538,156
+1.1%
0.00%0.0%
Q4 2016$1,886,000
+8.8%
532,540
+24.1%
0.00%0.0%
Q3 2016$1,733,000
-12.4%
428,964
-4.8%
0.00%0.0%
Q2 2016$1,978,000
+12.0%
450,733
-3.5%
0.00%0.0%
Q1 2016$1,766,000
-75.9%
467,229
-0.2%
0.00%
-50.0%
Q4 2015$7,338,000
+50.0%
467,986
+0.8%
0.00%
+100.0%
Q3 2015$4,892,000
-87.8%
464,228
-70.7%
0.00%
-90.9%
Q2 2015$40,008,000
-5.2%
1,586,378
+4.7%
0.01%0.0%
Q1 2015$42,221,000
-7.5%
1,514,926
-39.5%
0.01%
-8.3%
Q4 2014$45,664,000
+53.1%
2,502,063
+8.7%
0.01%
+50.0%
Q3 2014$29,823,000
-59.9%
2,301,161
-49.5%
0.01%
-20.0%
Q2 2014$74,396,000
+815.4%
4,558,584
+891.1%
0.01%
+400.0%
Q1 2014$8,127,000
-33.9%
459,940
-9.5%
0.00%
-33.3%
Q4 2013$12,298,000
-63.8%
508,015
-47.0%
0.00%
-40.0%
Q3 2013$33,968,000
+406.8%
958,734
+123.3%
0.01%
+150.0%
Q2 2013$6,702,000429,2950.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 844,981$15,421,0007.11%
DOHENY ASSET MANAGEMENT /CA 195,345$3,565,0001.70%
First Light Asset Management, LLC 153,617$2,804,0001.59%
Rhenman & Partners Asset Management AB 175,000$3,194,0000.93%
Iguana Healthcare Management, LLC 100,000$1,825,0000.88%
Eventide Asset Management 288,700$5,269,0000.58%
Bedell Frazier Investment Counselling, LLC 60,820$1,110,0000.54%
STONERIDGE INVESTMENT PARTNERS LLC 214,327$3,911,0000.52%
Fernwood Investment Management, LLC 31,350$572,0000.49%
SUFFOLK CAPITAL MANAGEMENT LLC 168,560$3,076,0000.37%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders